Del-desiran reduced DMPK mRNA levels, but led to two serious adverse events ...

Advancements in peptide and oligonucleotide synthesis via precision chemistry are transforming therapeutic development by ...

As Chief Editor of one of the two journals in which Biopharma Dealmakers appears, I have a keen interest in the process of translating biomedical research into new drugs, including the partnerships ...

OSAKA, Japan--(BUSINESS WIRE)--In response to the rapid market expansion of oligonucleotide therapeutics that have potential to treat both common and intractable diseases, Nitto Denko Corporation ...

Knowledge of gene function is required to utilize sequence information to develop new drugs to treat disease. In vitro techniques, such as antisense oligonucleotides (AS-ODNs) 1,2,3, ribozymes 4,5, ...

Strategic investments in ASO and siRNA platforms, coupled with breakthrough delivery technologies, position oligonucleotide ...

New York, USA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | ...

The use of oligonucleotides as therapeutic agents is of great interest, particularly when it comes to siRNA and antisense oligonucleotides. However, the difficulty of targeting the right organ and ...

Oligonucleotide therapeutics make up a small but rapidly growing segment of the overall global drug pipeline, with 245 programs currently in development today. While only one approved oligo ...

Creyon Bio, an oligonucleotide research specialist with the goal of designing precision medicines, has emerged with $40 million from a series A financing round led by DCVC Bio and Lux Capital. Creyon ...

DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides" report has been added ...

GSK has added another oligonucleotide to its pipeline, with potentially plenty more to follow courtesy of a $170 million upfront collaboration with Wave Life Sciences. As part of the deal, GSK will ...